Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties

Amino Acids

Volumn 48, Issue 2, 2016, Pages 505-522

  Han, Hyo Mi ^a   Gopal, Ramamourthy ^a   Park, Yoonkyung ^a  

^a Chosun University   (South Korea)

Author keywords

Anti biofilm; Antibiotic resistant bacteria; Antimicrobial peptide; Circular dichroism

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CIPROFLOXACIN; MYXINIDIN 2; MYXINIDIN 3; MYXINIDIN DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; FISH PROTEIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MYXINIDIN PEPTIDE, MYXINE GLUTINOSA; OLIGOPEPTIDE; PROTEIN BINDING; TEICHOIC ACID;

ALPHA HELIX; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; BETA SHEET; BINDING AFFINITY; BIOFILM; CELL SELECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG DESIGN; DRUG PENETRATION; DRUG PURIFICATION; DRUG SYNTHESIS; ESCHERICHIA COLI; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALT TOLERANCE; STAPHYLOCOCCUS AUREUS; CELL CULTURE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECTS; ERYTHROCYTE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KERATINOCYTE; METABOLISM; MICROBIAL SENSITIVITY TEST; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CIRCULAR DICHROISM; DRUG DESIGN; ERYTHROCYTES; FISH PROTEINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; KERATINOCYTES; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PROTEIN BINDING; SALT-TOLERANCE; STRUCTURE-ACTIVITY RELATIONSHIP; TEICHOIC ACIDS;

EID: 84958818341     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-2104-0     Document Type: Article

References (43)

1. Bhattachariya S, Ramamoorthy A (2009) Multifunctional host defense peptides: Functional and mechanistic insights from NMR structures of potent antimicrobial peptides. FEBS J 276(22):6465-6473
2. Bi X, Wang C, Ma L, Sun Y, Shang D (2013) Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action. J Appl Microbiol 115(3):663-672
3. Brogden KA (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238-250
4. Bruck E (1980) National Committee for Clinical Laboratory Standards. Pediatrics 65(1):187-188
5. Cantisani M, Leone M, Mignogna E, Kampanaraki K, Falanga A, Morelli G, Galdiero M, Galdiero S (2013) Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfish. Antimicrob Agents Chemother 57(11):5665-5673
6. Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S (2014) Structural insights into and activity analysis of the antimicrobial peptide myxinidin. Antimicrob Agents Chemother 58(9):5280-5290
7. Chan C, Burrows LL, Deber CM (2004) Helix induction in antimicrobial peptides by alginate in biofilms. J Biol Chem 279(37):38749-38754
8. Chan DI, Prenner EJ, Vogel HJ (2006) Tryptophan-and arginine-rich antimicrobial peptides: Structures and mechanisms of action. Biochim Biophys Acta 1758(9):1184-1202
9. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22(6):996-1006
10. Gopal R, Park JS, Seo CH, Park Y (2012) Applications of circular dichroism for structural analysis of gelatin and antimicrobial peptides. Int J Mol Sci 13(3):3229-3244
11. Gopal R, Lee JK, Lee JH, Kim YG, Oh GC, Seo CH, Park Y (2013a) Effect of repetitive lysine-tryptophan motifs on the eukaryotic membrane. Int J Mol Sci 14(1):2190-2202
12. Gopal R, Seo CH, Song PI, Park Y (2013b) Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Amino Acids 44(2):645-660
13. Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, Seo CH, Park Y (2014) Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 58(3):1622-1629
14. Hancock RE, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8(9):402-410
15. Hou M, Zhang N, Yang J, Meng X, Yang R, Li J, Sun T (2013) Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 32(3):614-623
16. Jamasbi E, Batinovic S, Sharples RA, Sani MA, Robins-Browne RM, Wade JD, Separovic F, Hossain MA (2014) Melittin peptides exhibit different activity on different cells and model membranes. Amino Acids 46(12):2759-2766
17. Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19(3):491-511
18. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 45(7):1169-1196
19. Liu YF, Xia X, Xu L, Wang YZ (2013) Design of hybrid b-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity. Biomaterials 34:237-250
20. Loh B, Grant C, Hancock RE (1984) Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 26(4):546-551
21. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 367(9524):1747-1757
22. Majer A, Kidric J, Jerala R (2003) Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J Antimicrob Chemother 51:1159-1165
23. Mayer LD, Hope MJ, Cullis PR (1986) Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 858(1):161-168
24. Mohamed MF, Hammac GK, Guptill L, Seleem MN (2014) Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs. PLoS ONE 9(12):e116259
25. Moore RA, Bates NC, Hancock RE (1986) Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother 29(3):496-500
26. Nan YH, Lee SH, Kim HJ, Shin SY (2010) Mammalian cell toxicity and candidacidal mechanism of Arg-or Lys-containing Trp-rich model antimicrobial peptides and their d-enantiomeric peptides. Peptides 31(10):1826-1831
27. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y (1999) Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: Relevance to the molecular basis for its non-cell-selective activity. Biochem J 341:501-513
28. Park Y, Lee DG, Jang SH, Woo ER, Jeong HG, Choi CH, Hahm KS (2003) A Leu-Lys-rich antimicrobial peptide: Activity and mechanism. Biochim Biophys Acta 1645(2):172-182
29. Park IY, Cho JH, Kim KS, Kim YB, Kim MS, Kim SC (2004) Helix stability confers salt resistance upon helical antimicrobial peptides. J Biol Chem 279(14):13896-13901
30. Park Y, Park SC, Park HK, Shin SY, Kim Y (2007) Hahm KS (2007) Structure-activity relationship of HP(2-20) analog peptide: Enhanced antimicrobial activity by N-terminal random coil region deletion. Biopolymers 88(2):199-207
31. Park SC, Park Y, Hahm KS (2011) The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci 12(9):5971-5992
32. Seo MD, Won HS, Kim JH, Mishig-Ochir T, Lee BJ (2012) Antimicrobial peptides for therapeutic applications: A review. Molecules 17(10):12276-12286
33. Silhavy TJ, Kahne D, Walker S (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2(5):a000414
34. Strempel N, Strehmel J, Overhage J (2015) Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections. Curr Pharm Des 21(1):67-84
35. Strom MB, Haug BE, Rekdal O, Skar ML, Stensen W, Svendsen JS (2002) Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochemistry and cell biology = Biochimie et biologie cellulaire 80(1):65-74
36. Subramanian S, Ross NW, MacKinnon SL (2009) Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Mar Biotechnol 11(6):748-757
37. Sun J, Xia Y, Li D, Du Q, Liang D (2014) Relationship between peptide structure and antimicrobial activity as studied by de novo designed peptides. Biochim Biophys Acta 1838(12):2985-2993
38. Takahashi D, Shukla SK, Prakash O, Zhang G (2010) Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie 92(9):1236-1241
39. Tran AX, Whittimore JD, Wyrick PB, McGrath SC, Cotter RJ, Trent MS (2006) The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J Bacteriol 188(12):4531-4541
40. Trauble H, Overath P (1973) The structure of Escherichia coli membranes studied by fluorescence measurements of lipid phase transitions. Biochim Biophys Acta 307:491-512
41. Wang K, Dang W, Yan J, Chen R, Liu X, Yan W, Zhang B, Xie J, Zhang J, Wang R (2013) Membrane perturbation action mode and structure-activity relationships of Protonectin, a novel antimicrobial peptide from the venom of the neotropical social wasp Agelaia pallipes pallipes. Antimicrob Agents Chemother 57(10):4632-4639
42. Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5(10):905-917
43. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27-55